Akso Health Group 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Akso Health Group reported a substantial net loss of $18.7 million for the fiscal year ended March 31, 2026, primarily driven by significant impairments on goodwill and intangible assets related to its prior acquisition of Tianjin Wangyi Cloud Technology Co., Ltd.
NASDAQ
Akso Health Group reported a significant net loss of $135.5 million for fiscal year 2025, driven by substantial impairment charges on acquired assets and ongoing operational challenges.
NASDAQ
Akso Health Group files its annual report on Form 20-F, detailing its financial performance and operational activities for the fiscal year ended March 31, 2024.